Nitric oxide inhalation as an interventional rescue therapy for COVID-19-induced acute respiratory distress syndrome

COVID-19 is an emerging disease of public health concern. While there is no specific recommended treatment for COVID-19, nitric oxide has the potential to be of therapeutic value for managing acute respiratory distress syndrome in patients with COVID-19. However, inhaled nitric oxide has not yet bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Jun, Murata, Isamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238394/
https://www.ncbi.nlm.nih.gov/pubmed/32436029
http://dx.doi.org/10.1186/s13613-020-00681-9
_version_ 1783536529492148224
author Kobayashi, Jun
Murata, Isamu
author_facet Kobayashi, Jun
Murata, Isamu
author_sort Kobayashi, Jun
collection PubMed
description COVID-19 is an emerging disease of public health concern. While there is no specific recommended treatment for COVID-19, nitric oxide has the potential to be of therapeutic value for managing acute respiratory distress syndrome in patients with COVID-19. However, inhaled nitric oxide has not yet been formally evaluated. Given the extent of the COVID-19 pandemic, and the large numbers of hospitalized patients requiring respiratory support, clinical use of inhaled nitric oxide may become an alternate rescue therapy before extracorporeal membrane oxygenation for the management of acute respiratory distress syndrome in patients with COVID-19.
format Online
Article
Text
id pubmed-7238394
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-72383942020-05-20 Nitric oxide inhalation as an interventional rescue therapy for COVID-19-induced acute respiratory distress syndrome Kobayashi, Jun Murata, Isamu Ann Intensive Care Letter to the Editor COVID-19 is an emerging disease of public health concern. While there is no specific recommended treatment for COVID-19, nitric oxide has the potential to be of therapeutic value for managing acute respiratory distress syndrome in patients with COVID-19. However, inhaled nitric oxide has not yet been formally evaluated. Given the extent of the COVID-19 pandemic, and the large numbers of hospitalized patients requiring respiratory support, clinical use of inhaled nitric oxide may become an alternate rescue therapy before extracorporeal membrane oxygenation for the management of acute respiratory distress syndrome in patients with COVID-19. Springer International Publishing 2020-05-20 /pmc/articles/PMC7238394/ /pubmed/32436029 http://dx.doi.org/10.1186/s13613-020-00681-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter to the Editor
Kobayashi, Jun
Murata, Isamu
Nitric oxide inhalation as an interventional rescue therapy for COVID-19-induced acute respiratory distress syndrome
title Nitric oxide inhalation as an interventional rescue therapy for COVID-19-induced acute respiratory distress syndrome
title_full Nitric oxide inhalation as an interventional rescue therapy for COVID-19-induced acute respiratory distress syndrome
title_fullStr Nitric oxide inhalation as an interventional rescue therapy for COVID-19-induced acute respiratory distress syndrome
title_full_unstemmed Nitric oxide inhalation as an interventional rescue therapy for COVID-19-induced acute respiratory distress syndrome
title_short Nitric oxide inhalation as an interventional rescue therapy for COVID-19-induced acute respiratory distress syndrome
title_sort nitric oxide inhalation as an interventional rescue therapy for covid-19-induced acute respiratory distress syndrome
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238394/
https://www.ncbi.nlm.nih.gov/pubmed/32436029
http://dx.doi.org/10.1186/s13613-020-00681-9
work_keys_str_mv AT kobayashijun nitricoxideinhalationasaninterventionalrescuetherapyforcovid19inducedacuterespiratorydistresssyndrome
AT murataisamu nitricoxideinhalationasaninterventionalrescuetherapyforcovid19inducedacuterespiratorydistresssyndrome

Ejemplares similares